Inmunología, Oftalmología y ORL
Département
Hamad Medical Corporation
Doha, QatarPublications en collaboration avec des chercheurs de Hamad Medical Corporation (1)
2018
-
Mutations in PI3K110δ cause impaired natural killer cell function partially rescued by rapamycin treatment
Journal of Allergy and Clinical Immunology, Vol. 142, Núm. 2, pp. 605-617.e7